This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Vertex Pharmaceuticals Inc (VRTX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 569.30M 489.41M 475.32M 243.20M
Receivables 85.52M 143.25M 183.14M 12.53M
Inventories 14.15M 30.46M 112.43M 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 1.59B 1.59B 1.33B 1.06B
Property, Plant & Equipment, Gross 1.01B 730.29M 404.24M 319.65M
Accumulated Depreciation & Depletion 308.34M 296.68M 271.06M 247.32M
Property, Plant & Equipment, Net 696.91M 433.61M 133.18M 72.33M
Intangibles 0.00 663.50M 663.50M 518.70M
Other Non-Current Assets 2.56M 41.60M 45.36M 51.27M
Total Non-Current Assets 730.46M 1.17B 873.03M 668.41M
Liabilities & Shareholder Equity
Total Assets 2.32B 2.76B 2.20B 1.73B
Accounts Payable 67.66M 130.30M 74.64M 35.85M
Short Term Debt 16.89M 13.71M 0.00 0.00
Other Current Liabilities 33.10M 41.53M 12.08M 83.95M
Total Current Liabilities 397.83M 432.62M 392.35M 474.78M
Long Term Debt 0.00 400.00M 400.00M 400.00M
Deferred Income Taxes 0.00 280.37M 243.71M 160.28M
Other Non-Current Liabilities 75.12M 167.24M 239.75M 186.41M
Minority Interest -242.52M 55.90M 11.60M 0.00
Total Non-Current Liabilities 564.81M 1.33B 1.03B 746.69M
Total Liabilities 962.64M 1.76B 1.42B 1.22B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 1.36B 999.18M 786.84M 503.97M
Common Par 2.32M 2.15M 2.07M 2.02M
Additional Paid In Capital 5.32B 4.52B 4.20B 3.95B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -3.97B -3.52B -3.41B -3.44B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -306.00K -550.00K -1.05M -1.07M
Total Capitalization 1.36B 1.40B 1.19B 903.97M
Total Equity 1.36B 999.18M 786.84M 503.97M
Total Liabilities & Stock Equity 2.32B 2.76B 2.20B 1.73B
Total Common Shares Outstanding 233.79M 217.29M 209.30M 203.52M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 224.91M 211.95M 204.89M 200.40M
Diluted Weighted Shares Outstanding 224.91M 211.95M 208.81M 200.40M
Number of Employees 1800 2200 2000 1691
Number of Part-Time Employees 0 0 0 0
VRTX News

VRTX Vertex Pharmaceuticals Inc

Analysts Ratings for VRTX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 9 9 10 10
Moderate Buy 0 0 0 0
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET VRTX ANALYST REPORT

Brokerage Partners

VRTX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs